首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3530篇
  免费   220篇
  国内免费   30篇
耳鼻咽喉   1篇
儿科学   219篇
妇产科学   83篇
基础医学   399篇
口腔科学   143篇
临床医学   323篇
内科学   806篇
皮肤病学   245篇
神经病学   128篇
特种医学   500篇
外国民族医学   9篇
外科学   284篇
综合类   59篇
一般理论   6篇
预防医学   194篇
眼科学   29篇
药学   183篇
  1篇
中国医学   4篇
肿瘤学   164篇
  2021年   39篇
  2019年   35篇
  2018年   62篇
  2017年   38篇
  2016年   51篇
  2015年   48篇
  2014年   60篇
  2013年   96篇
  2012年   87篇
  2011年   94篇
  2010年   70篇
  2009年   123篇
  2008年   95篇
  2007年   119篇
  2006年   125篇
  2005年   104篇
  2004年   95篇
  2003年   100篇
  2002年   83篇
  2001年   58篇
  2000年   85篇
  1999年   74篇
  1998年   117篇
  1997年   126篇
  1996年   124篇
  1995年   85篇
  1994年   92篇
  1993年   122篇
  1992年   73篇
  1991年   67篇
  1990年   74篇
  1989年   110篇
  1988年   94篇
  1987年   73篇
  1986年   79篇
  1985年   97篇
  1984年   62篇
  1983年   51篇
  1982年   31篇
  1981年   54篇
  1980年   39篇
  1979年   56篇
  1978年   37篇
  1977年   38篇
  1976年   45篇
  1973年   29篇
  1972年   25篇
  1971年   29篇
  1970年   25篇
  1967年   22篇
排序方式: 共有3780条查询结果,搜索用时 0 毫秒
41.
Abnormal clonogenic potential of T cells from multiple myeloma patients   总被引:2,自引:0,他引:2  
Peripheral blood lymphocytes (PBLs) from multiple myeloma patients are defective in both proportion and absolute numbers of OKT4+ cells and have a normal proportion but reduced absolute number of OKT8+ cells. To assess the functional capabilities of the T cells in myeloma patients, we cloned the T cells in PBLs using limiting dilution conditions in which 100% of OKT4+ and OKT8+ T cells in normal PBLs are able to form a clone. In contrast, the OKT8+ cells from PBLs of five of seven multiple myeloma patients were severely compromised in their clonogenic potential; only 7% to 25% of OKT8+ T cells appeared to give rise to a clone. Clonogenic potential of the OKT4+ cells in patients was more nearly normal. Analysis of two multiple myeloma patients with abnormally low numbers of T cells in PBLs revealed the existence of abnormalities in the progenitors of T cell clones. In both patients, two to three times as many T cell clones were observed as would have been expected based on the number of PBLs cultured at limiting dilution, indicating that OKT4-8- cells in PBLs are capable of giving rise to OKT4+ and, at lower frequency, to OKT8+ clonal progeny in vitro. We conclude that purely quantitative assessment of T cell subsets should be interpreted with caution, since proportionately normal numbers of OKT8+ cells in patient PBLs are seriously compromised in their ability to give rise to clonal progeny in vitro, and since there appears to be a OKT4-8- population of T cells in PBLs that are committed to become OKT4+ or OKT8+ T cells, but are unable to do so in vivo.  相似文献   
42.
The problem of a possible interaction between amiodarone and digoxin is still unsettled. We have recently treated two patients with digoxin intoxication who had received amiodarone for eight and 36 months respectively. Both developed extreme bradycardia requiring temporary pacemakers. The presence of hypothyroidism was confirmed in both cases by laboratory data. Judging by present knowledge concerning the interaction between amiodarone, thyroid function, and digoxin, it is suggested that digoxin intoxication was not the result of its direct interaction with amiodarone. The possibility that amiodarone-induced hypothyroidism precipitated digoxin intoxication seems to be more plausible. Prevention of digitalis toxicity in amiodarone-treated patients would therefore require monitoring of thyroid function every three to six months. Frequent monitoring of digitalis blood levels is also indicated in patients with amiodarone associated hypothyroidism. Early detection of hypothyroidism and digitalis intoxication is necessary in view of the severity of the course of the disease.  相似文献   
43.
Pediatric knee MR imaging: pattern of injuries in the immature skeleton   总被引:3,自引:0,他引:3  
  相似文献   
44.
Periosteal Ewing sarcoma   总被引:3,自引:0,他引:3  
  相似文献   
45.
46.
47.
48.
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号